ArticleJournal of human hypertension2008
Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions.
Article in Journal of human hypertension, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed.
- Nurse-led hypertension management was well accepted and non-inferior to physician consultation in a Chinese population: a randomized controlled trial.Scientific reports · 2018Trial
- Antihypertensive drug class and impaired fasting glucose: a risk association study among Chinese patients with uncomplicated hypertension.BMC clinical pharmacology · 2008Trial
- Impact of pooled procurement of medicines on patient adherence and economic burden: evidence from China.Journal of global health · 2025Article
- Management of Hypertension in the Asia-Pacific Region: A Structured Review.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2024Review
- Antihypertensive treatments and risks of lung Cancer: a large population-based cohort study in Hong Kong.BMC cancer · 2021Article
- Article
- Prescribing Patterns of Antihypertensives for Treatment-Naïve Patients in South Korea: From Korean NHISS Claim Data.International journal of hypertension · 2019Article
- Using Classification and Regression Trees (CART) to Identify Prescribing Thresholds for Cardiovascular Disease.PharmacoEconomics · 2016Article
- Cost-effectiveness of amlodipine compared with valsartan in preventing stroke and myocardial infarction among hypertensive patients in Taiwan.International journal of general medicine · 2016Article
- Initial antihypertensive prescription and switching: a 5 year cohort study from 250,851 patients.PloS one · 2013Article
- The healthcare burden of hypertension in Asia.Heart Asia · 2013Article
- Switching of antihypertensive drugs among 93,286 Chinese patients: a cohort study.Journal of human hypertension · 2010Article
- Individuals at risk of beta-blocker discontinuation: a cohort study in 19,177 Chinese patients.Clinical research in cardiology : official journal of the German Cardiac Society · 2010Article
- Profiles of mortality among Chinese hypertensive patients in Hong Kong: a cohort study.Journal of human hypertension · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
To evaluate the prescription, discontinuation and switching profiles of antihypertensive agents, we studied computerized records for patients prescribed antihypertensive drugs in government primary care clinics of Hong Kong between January 2004 and June 2007, which include 1069836 antihypertensive drug visits (representing 67028 patients). The most commonly prescribed drugs were calcium channel blockers (CCBs, 49%), beta-blockers (BBs, 46%) and angiotensin-converting enzyme inhibitors (ACEIs, 19%). Although thiazide diuretic prescribing was low (13%) and on the decline (from 14% in 2004 to 12% in 2007), prescription of ACEIs was rising (from 16% in 2004 to 23% in 2007); drug discontinuation was highest for BBs (21%) and lowest for CCBs (12%) and the high rates of discontinuation in BBs remained apparent after controlling for confounders. CCBs may be particularly favourable antihypertensive drugs in Chinese and the low use of thiazide diuretics warrants further clinical and cost effectiveness studies among Chinese.
Indexed as
Identifiers
18650836What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.